This inventor holds 3 USPTO granted patents and 5 published patent applications, plus 2 CIPO patents and 5 EPO patents. Top assignee: Axiogenesis Ag. Active years: 2012-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012-2017
Title: Unveiling the Innovative Path of Andreas Ehlich: A Pioneer in Stem Cell-Based Research
Introduction:
Andreas Ehlich, a distinguished inventor hailing from Mechernich, Germany, has made significant strides in the realm of stem cell-based research and development. With an impressive portfolio of 3 patents to his name, Andreas has been at the forefront of pioneering technologies that have the potential to revolutionize the fields of drug discovery and tissue modeling.
Latest Patents:
1. "Assay for drug discovery based on in vitro differentiated cells": Andreas' groundbreaking work in this domain has led to the development of assay systems that enable the evaluation of the therapeutic or toxic effects of potential drugs on in vitro differentiated cells. By closely simulating disease phenotypes in these cells, researchers can gain valuable insights into the efficacy and safety of novel pharmaceutical compounds.
2. "Tissue modeling in embryonic stem (ES) cell system": Andreas' innovative approach involves the creation of tissue modeling systems using embryonic stem cells. These systems allow for the generation of complex tissues through the selection and differentiation of specific cell types, offering a novel platform for drug development and transplantation studies.
Career Highlights:
Andreas Ehlich currently lends his expertise to Axiogenesis AG, a leading research institution specializing in stem cell technologies. His contributions to the field have not only advanced the scientific community's understanding of stem cell biology but have also laid the foundation for cutting-edge applications in drug discovery and regenerative medicine.
Collaborations:
Throughout his career, Andreas has collaborated closely with esteemed colleagues such as Heribert Bohlen and Kristina Jönsson. Together, they have fostered a culture of innovation and excellence, driving forward collaborative research initiatives that have garnered international recognition.
Conclusion:
In conclusion, Andreas Ehlich stands as a beacon of innovation in the field of stem cell research, with a proven track record of transformative inventions that have the potential to shape the future of healthcare and biotechnology. His relentless pursuit of scientific excellence and commitment to pushing the boundaries of knowledge exemplify the essence of a true visionary in the world of inventions and innovations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile